AvandiaGate: Silencing A Critic

Source: Pharmalot

Did Glaxo try to intimidate John Buse into keeping his mouth shout about his concerns with the diabetes drug? Congressional investigators are examining what they call “very serious” claims that Glaxo “silenced one or more medical professionals who attempted to speak out about the potential for cardiovascular problems with Avandia,” according to a letter sent to Glaxo last week from the Senate Finance Committee.

FULL STORY HERE